MANTA Not Superior to Dual Perclose ProGlides for Large-Bore Arteriotomy Closure in TAVR, Pilot Trial Shows
An international, two-center, pilot randomized controlled trial of 210 transcatheter aortic valve replacement (TAVR) patients found that the MANTA vascular closure device (VCD) was not superior to dual Perclose ProGlide (PP) closure with regard to access-site-related vascular complications for large-bore arteriotomy closure in TAVR, results released Wednesday show.